The Rapid Developments In Minimally Invasive Treatments Is Anticipated To Openup The New Avenues For Inflation Devices Market

Inflation Devices Market Size
Inflation Devices Market Size



The Inflation Devices Market is estimated to be valued at US$ 4.64 Bn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Inflation devices are medical devices used to inflate objects such as balloons, catheters, and stents during minimally invasive procedures. They are used in procedures like angioplasty, stent placement, catheters insertion and dilation, and intra-aortic balloon pumps insertion. The devices can either be manual or electric and are compatible with a variety of balloons and catheters.

Market Dynamics:
Inflation devices offer advantages like accuracy, precision, control, and simplicity of operation. They help inflate devices to desired pressure levels accurately. They integrate safety features to avoid over inflation which can damage tissues.

Driver 1 - Growing prevalence of target diseases: Inflation devices predominantly find application in vascular diseases like coronary artery disease and peripheral artery disease which are on the rise globally due to changing lifestyles. High blood pressure, diabetes, and obesity increase the risks of these diseases thereby driving the demand for inflation devices.

Driver 2 - Rising preference for minimally invasive surgeries: Minimally invasive procedures require inflation devices to insert and place devices like balloons and stents accurately. As these procedures are preferred over open surgeries due to benefits like lesser pain, quick recovery, and good cosmetic outcomes - demand for inflation devices is increasing.
Segment Analysis

The global Inflation Devices Market Size is dominated by the gastric devices segment. Gastric devices help in reducing complications during bariatric procedures and are painless. These devices are used to dilate and inflate the stomach to reduce its size and hold. The procedure involves placing an inflation device into the stomach through the mouth and inflating it to reduce the stomach capacity. This segment dominates due to the increasing prevalence of obesity and growing adoption of bariatric surgeries.

PEST Analysis

Political: Regulations regarding safety and efficacy of medical devices are favorable for market growth. Economic: Rising healthcare spending and growing economy in emerging nations is driving market growth. Social: Increasing obesity rates due to sedentary lifestyle and changing food habits is increasing demand. Technological: Advancements in gastric balloons and band technologies are helping to improve treatment outcomes.

Key Takeaways

The global inflation devices market size is expected to reach US$ 6.56 Bn by 2030, expanding at a CAGR of 8.0% during the forecast period. The rising number of bariatric surgeries due to increasing obese population is one of the major drivers. Regionally, North America dominates the market currently due to high awareness and supportive reimbursement policies for weight management surgeries in the region. Key players operating in the inflation devices market are Medtronic, Boston Scientific, Abbott Laboratories, Teleflex, ConvaTec, Smiths Group, Cook Medical, B. Braun Melsungen, Cardinal Health, and Stryker.

The North American region is expected to continue dominating the market through the forecast period, expanding at a CAGR of 7.5%. This can be attributed to factors such as growing obese population, rising incidence of gastrointestinal diseases, increasing focus on endoscopic operations, and supportive reimbursement policies for bariatric surgeries in the region.

Key players operating in the inflation devices market are focusing on new product launches. For instance, in February 2022, Boston Scientific received FDA approval for its Orbera Intragastric Balloon System with Bioabsorbable Retention System (BioAbsorvable Intragastric Balloon orBIB) for six months of weight loss. The new BIB system features a fully bioabsorbable retention design that dissolves after six months, eliminating the need for balloon removal.


Read More: https://www.rapidwebwire.com/inflation-devices-market-scope/

Post a Comment

Previous Post Next Post